The latest pharmacotherapeutic options for the treatment of IgA nephropathy in the pediatric population
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.IgA nephropathy (IgAN) treatment lacks pediatric guidelines. This review covers new therapies for IgAN in children, focusing on adult trial drugs and pediatric case studies.
Area Of Science
- Nephrology
- Pediatric Nephrology
- Immunology
Background
- Immunoglobulin A nephropathy (IgAN) is the most prevalent chronic glomerulonephritis globally.
- Pediatric IgAN management lacks evidence-based treatment recommendations and therapeutic options.
- Children exhibit higher disease activity and longer life expectancy, necessitating tailored treatments.
Purpose Of The Study
- To provide a comprehensive overview of current therapeutic strategies for IgAN in children.
- To highlight novel treatments evaluated in adult cohorts and reported in pediatric case studies.
- To emphasize the need for pediatric clinical trials in IgAN management.
Main Methods
- Literature search conducted on PubMed and Scopus from January 2013 to June 2025.
- Inclusion of studies relevant to IgAN treatment strategies in pediatric patients.
- Focus on recent adult trials and pediatric case studies of novel therapies.
Main Results
- Numerous adult trials are investigating medications targeting fundamental IgAN pathogenetic pathways.
- Promising results in adult trials include proteinuria reduction and kidney function stabilization.
- Emerging novel treatments show potential in pediatric case studies.
Conclusions
- There is a critical need to evaluate modern therapies in children with IgAN.
- Prioritizing pediatric clinical trials for IgAN is crucial.
- Addressing barriers to pediatric clinical trial implementation is essential for advancing treatment.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
While some alleles of a given gene might be observed commonly, other variants...
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
However, realistic environmental conditions limit the number of...
Overview
Populations are groups of individuals of the same species that inhabit a shared environment. Communities include multiple co-existing, interacting populations of different species. Metapopulations span multiple populations of the same species that occupy different areas. Metapopulations interact through immigration and emigration, providing genetic diversity that lends resilience to harsh environments. Population size and density can be estimated using quadrat and mark and recapture...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...